Loading company…
Qureator develops organ-on-a-chip platforms and software for drug development.
Founded in 2016, Qureator develops micro-physiological systems and organ-on-a-chip platforms for drug development, along with AI-enabled data management software. Based in California, the company raised KRW 3 billion in venture funding from Insight Equity Partners in June 2026, at a post-money valuation of KRW 32 billion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in